Odyssey Health (ODYY) Shares Outstanding (Diluted Average) (2021 - 2026)
Odyssey Health's quarterly Shares Outstanding (Diluted Average) came in at $106.9 million in Q1 2026, up 2.13% year-on-year from $104.7 million in Q1 2025, and up 0.86% quarter-over-quarter from $106.0 million in Q4 2025.
Odyssey Health has reported Shares Outstanding (Diluted Average) for 6 years, with the latest figure at $106.9 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 2.13% year-over-year to $106.9 million; the trailing twelve-month figure through Jan 2026 stood at $106.9 million (up 2.13% YoY), and the FY2025 full-year result was $104.7 million, up 7.88% from the prior year.
- Shares Outstanding (Diluted Average) for Q1 2026 stood at $106.9 million, up from $106.0 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $114.1 million in Q1 2024, with the low at $80.9 million in Q4 2022.
- Average Shares Outstanding (Diluted Average) over 5 years is $95.8 million, with a median of $97.1 million recorded in 2024.
- Year-over-year, Shares Outstanding (Diluted Average) declined 10.63% in 2023 and soared 39.75% in 2024.
- Tracing ODYY's Shares Outstanding (Diluted Average) over 5 years: stood at $80.9 million in 2022, then grew by 0.16% to $81.0 million in 2023, then advanced by 29.24% to $104.7 million in 2024, then rose by 1.27% to $106.0 million in 2025, then gained by 0.86% to $106.9 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $106.9 million (Q1 2026), $106.0 million (Q4 2025), and $104.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Odyssey Health | - | - | - | 106.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 106.95 Mn |
| Oct 31, 2025 | 106.04 Mn |
| Jul 31, 2025 | 104.71 Mn |
| Apr 30, 2025 | 104.71 Mn |
| Jan 31, 2025 | 104.71 Mn |
| Oct 31, 2024 | 104.71 Mn |
| Jul 31, 2024 | 97.06 Mn |
| Apr 30, 2024 | 113.90 Mn |
| Jan 31, 2024 | 114.06 Mn |
| Oct 31, 2023 | 81.02 Mn |
| Jul 31, 2023 | 82.68 Mn |
| Apr 30, 2023 | 81.84 Mn |
| Jan 31, 2023 | 81.62 Mn |
| Oct 31, 2022 | 80.89 Mn |
| Jul 31, 2022 | 89.00 Mn |
| Apr 30, 2022 | 83.95 Mn |
| Jan 31, 2022 | 91.32 Mn |
| Oct 31, 2021 | 88.06 Mn |
| Jul 31, 2021 | 93.73 Mn |
| Apr 30, 2021 | 93.38 Mn |